Lemtrada and Basedow's disease - a phase IV clinical study of FDA data

Summary:

Basedow's disease is found among people who take Lemtrada, especially for people who are female, 30-39 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Lemtrada and have Basedow's disease. It is created by eHealthMe based on reports of 7,751 people who have side effects when taking Lemtrada from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 30, 2023

7,751 people reported to have side effects when taking Lemtrada.
Among them, 138 people (1.78%) have Basedow's disease.


What is Lemtrada?

Lemtrada has active ingredients of alemtuzumab. eHealthMe is studying from 7,770 Lemtrada users for its effectiveness, alternative drugs and more.

What is Basedow's disease?

Basedow's disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones) is found to be associated with 752 drugs and 382 conditions by eHealthMe.

Number of Lemtrada and Basedow's disease reports submitted per year:

Could Lemtrada cause Basedow's disease?

Time on Lemtrada when people have Basedow's disease *:

Click here to view

Gender of people who have Basedow's disease when taking Lemtrada*:

Click here to view

Age of people who have Basedow's disease when taking Lemtrada *:

Click here to view

Common drugs people take besides Lemtrada *:

Click here to view

Common side effects people have besides Basedow's disease *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Lemtrada and have Basedow's disease?

Check whether Basedow's disease is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Basedow's disease and when was it recovered:

Expand to all the drugs that have ingredients of alemtuzumab:

Alternative drugs to, pros and cons of Lemtrada:

Common Lemtrada side effects:

Browse all side effects of Lemtrada:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Basedow's disease treatments and more:

COVID vaccines that are related to Basedow's disease:

Common drugs associated with Basedow's disease:

All the drugs that are associated with Basedow's disease:

Common conditions associated with Basedow's disease:

All the conditions that are associated with Basedow's disease:

How the study uses the data?

The study uses data from the FDA. It is based on alemtuzumab (the active ingredients of Lemtrada) and Lemtrada (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: